Pharbaco Central Pharmaceutical Joint Stock Company I is a premier pharmaceutical manufacturer and distributor based in Hanoi, Vietnam. Established in 1954, the company has a 70-year history as a cornerstone of the national pharmaceutical industry. Operating as a manufacturer, trading company, and OEM/contract manufacturer, Pharbaco maintains a workforce of 501 to 1,000 employees and manages a significant production complex in Soc Son District. The company is recognized for its extensive manufacturing capabilities, featuring modern production lines from Germany, the UK, and the US, and holds certifications including WHO-GMP, EU-GMP, GLP, and GSP.
Pharbaco offers a diverse portfolio of over 500 products across various therapeutic categories, including antibiotics (Cephalosporin, Penicillin, and Carbapenem), cardiovascular medications, anti-inflammatory drugs, vitamins, and dietary supplements. Their production facilities include specialized lines for injectable powders, oral solid dosages (OSD), and traditional medicinal herbs. Beyond pharmaceuticals, the company is involved in the supply of medical equipment, cosmetics, and specialized drugs for national health programs targeting tuberculosis and malaria.
With a strong focus on research and development, Pharbaco operates international-standard laboratories and R&D centers in Hanoi and Ho Chi Minh City. The company has a robust international trade presence, exporting high-quality Vietnamese medicines to over 20 countries and territories worldwide. Listed on the UPCOM market under the ticker PBC, Pharbaco continues to expand its scale through multi-phase factory upgrades to meet evolving global healthcare standards.
OEM manufacturerOffers OEM services for customized brand manufacturing.
High capacity factoryCan handle large-scale or bulk production orders.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Established brandFounded in 1954, with over 20 years of industry experience.
Contact
*************************
4
************************
5
Products
Fabafixim
Cefadroxil 250mg
Introduce | Pharbaco
Pharbaco factory
Pharbaco Building
Pharbaco Central Pharmaceutical Joint Stock Company
Customers
KKC
13 shipments
********************
No shipments
*****
No shipments
**********
No shipments
*********
No shipments
Unlock all 21 customers
Unlock
Certifications
GMP
7
Good Manufacturing Practice
GS
1
Geprüfte Sicherheit
Ask AI about this supplier
Curious about this supplier? Ask AI for a quick overview.
Key export market
🇻🇳 Vietnam🇻🇳 Vietnam
🇰🇭 Cambodia🇰🇭 Cambodia
🇲🇳 Mongolia🇲🇳 Mongolia
🇲🇲 Myanmar🇲🇲 Myanmar
🇨🇳 China🇨🇳 China
🇨🇩 DR Congo🇨🇩 DR Congo
EuropeEurope
AsiaAsia
AfricaAfrica
🇲🇩 Moldova🇲🇩 Moldova
🇳🇬 Nigeria🇳🇬 Nigeria
🇾🇪 Yemen🇾🇪 Yemen
🇨🇬 Congo Republic🇨🇬 Congo Republic
🇵🇬 Papua New Guinea🇵🇬 Papua New Guinea
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customers
Top 5 customers
This insight is only available in the Pro plan
Top 5 export countries
Reflecting the supplier's export experience in target countries
Top 5 export countries
This insight is only available in the Pro plan
Shipment count distribution
Reflecting the supplier's market business activity
All categories
Loading chart data...
Shipment count distribution
This insight is only available in the Pro plan
Export weight distribution (kg)
Reflecting the supplier's export scale
All categories
Loading chart data...
Export weight distribution (kg)
This insight is only available in the Pro plan
Export weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughs
All categories
Loading chart data...
Export weight trend (kg)
This insight is only available in the Pro plan
CIF trend (USD)
For identifying high-value cooperation periods and single order value changes
All categories
Loading chart data...
CIF trend (USD)
This insight is only available in the Pro plan
Similar suppliers you may like
Thanh Hoa Medical Materials Pharmaceutical Joint Stock Company
Thanh Hoa Medical Materials Pharmaceutical Joint Stock Company (THEPHACO) is a premier Vietnamese pharmaceutical manufacturer and distributor with a history dating back to 1961. Headquartered in Thanh Hoa, the company operates as a large-scale enterprise with nearly 1,000 employees and a robust infrastructure that includes three GMP-standardized factories specializing in Western medicines, Oriental medicines, and health supplements. THEPHACO is recognized for its advanced manufacturing capabilities, including a soft capsule production line with an annual capacity of 240 million units, and it maintains high-quality standards with WHO-GMP, HS-GMP, and ISO 9001:2015 certifications.
The company's extensive product portfolio features nearly 200 items, ranging from antibiotics (such as Cefadozil 1000) and vitamin supplements to herbal medicines, electrolyte drinks, and lung tonics. Beyond pharmaceuticals, the company is a significant provider of medical equipment and supplies, including diagnostic imaging systems, dialysis fluids, surgical equipment, and home medical devices. Through its subsidiary THEMCO, it also offers specialized medical gas systems and healthcare IT solutions.
As a vertically integrated business, THEPHACO functions as a manufacturer, wholesaler, and exporter with a distribution network spanning domestic and international markets. The company operates over 40 branches across Vietnam, including major hubs in Hanoi and Ho Chi Minh City, and maintains a subsidiary in Laos. With a commitment to research and development, THEPHACO serves major healthcare institutions such as Bach Mai Hospital and continues to expand its global footprint through OEM and contract manufacturing services.
G- Xtill- 500
Caltor
Gabcure
Daxame
G-Xtil-500
Caltor
Gabcure
Acecicys 200
Cefpocin 200
Lantota
Vidipha Central Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
2003101-200 peopleManufacturer/Distributor/Service Company
Established brand
OEM manufacturer
Shipments
96
Key customer
MED AGRO
Key market
🇻🇳 Vietnam
Description
Vidipha Central Pharmaceutical Joint Stock Company is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. With a history spanning 48 years and over two decades operating as a joint-stock enterprise, the company has established itself as a key player in the healthcare sector, employing between 101 and 200 professionals. Vidipha operates a dedicated manufacturing facility and has maintained a GMP-certified quality system for over 23 years, ensuring high standards across its diverse product portfolio. The company specializes in the production of treatment drugs, health protection foods, and medical equipment. Its extensive pharmaceutical range includes antibiotics, analgesics, antipyretics, antivirals, antihistamines, and specialized treatments for cardiovascular, respiratory, gastrointestinal, and dermatological conditions. Notable products include Acyclovir, Amoxycilin, and Gludipha. Beyond manufacturing, Vidipha offers OEM services, drug storage, testing, and technology transfer consulting. The company is listed on the Ho Chi Minh Stock Exchange (VDP) and serves a network of over 10,000 customers through five regional branches. Its manufacturing capabilities cover various dosage forms, including tablets, liquids, powders, and ointments.